Ospel, Johanna Maria
Kashani N, Nima
Menon, Bijoy
Almekhlafi, Mohammed
Wilson, Alexis
Fischer, Urs
Campbell, Bruce
Yoshimura, Shinichi
Turjman, Francis
Cherian, Mathew
Heo, Ji-Hoe
Hill, Michael
Saposnik, Gustavo
Goyal, Mayank
Article History
Received: 23 September 2019
Accepted: 17 October 2019
First Online: 8 November 2019
Compliance with ethical guidelines
:
: J.M. Ospel is supported by the University of Basel Research Foundation, the Julia Bangerter Rhyner Foundation and the “Freiwillige Akademische Gesellschaft Basel” Foundation. U. Fischer is a consultant for Medtronic, Stryker and CSL Behring and Co-Principal Investigator of SWIFT-DIRECT, a randomized controlled endovascular stroke treatment trial (Medtronic). F. Turjman works as a consultant for Balt and Stryker. G. Saposnik is supported by the Heart and Stroke Foundation of Canada Career Award. M. Goyal is a consultant for Medtronic, Stryker, Microvention, GE Healthcare, Mentice. N. Kashani N, B. Menon, M. Almekhlafi, A. Wilson, B. Campbell, S. Yoshimura, M. Cherian, J.-H. Heo and M. Hill declare that they have no competing interests.
: For this article no studies with human patients or animals were performed by any of the authors. All studies performed were in accordance with the ethical standards indicated in each case.